EGFR and chordoma: Activation of the PI3K/AKT/TSC1/TSC2/mTOR signaling pathway [10], overexpression of receptor tyrosine kinases (such as EGFR), as well as activation of IGF1R were described in chordoma and were considered as targets for tailored therapy [11, 12].